Johnson & Johnson (JNJ) Change in Accured Expenses (2009 - 2026)

Johnson & Johnson has disclosed Change in Accured Expenses across 18 years of filings, most recently posting -$629.0 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$629.0 million, up 90.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $183.0 million (up 104.58% YoY), and the FY2025 annual result was -$5.7 billion, down 17363.64% from the prior year.
• Change in Accured Expenses came in at -$629.0 million for Q1 2026 at Johnson & Johnson, down from $499.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.0 billion in Q3 2023 to a low of -$6.5 billion in Q1 2025.
• The 5-year median for Change in Accured Expenses is -$629.0 million (2026), against an average of -$173.7 million.
• Across the five-year window, Change in Accured Expenses surged 263.32% in 2023 and tumbled 585.16% in 2025, its largest moves.
• Johnson & Johnson's Change in Accured Expenses stood at -$2.8 billion in 2022, then surged by 218.14% to $3.3 billion in 2023, then tumbled by 89.21% to $359.0 million in 2024, then jumped by 39.0% to $499.0 million in 2025, then plunged by 226.05% to -$629.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$629.0 million (Q1 2026), $499.0 million (Q4 2025), and -$5.3 billion (Q3 2025), per Business Quant data.